Accrued Liabilities, Current of Enlivex Therapeutics Ltd. from 31 Dec 2013 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Enlivex Therapeutics Ltd. quarterly Accrued Liabilities, Current in USD history and change rate from 31 Dec 2013 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Accrued Liabilities, Current for the quarter ending 30 Jun 2025 was $2,786,000.
Source SEC data
View on sec.gov
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,786,000 30 Jun 2025 6-K 29 Aug 2025 2025 Q2
Q4 2024 $2,846,000 -$1,155,000 -29% 31 Dec 2024 6-K 29 Aug 2025 2025 Q2
Q4 2023 $4,001,000 -$658,000 -14% 31 Dec 2023 20-F 30 Apr 2025 2024 FY
Q4 2022 $4,659,000 31 Dec 2022 20-F 30 Apr 2024 2023 FY
Q4 2018 $19,000 -$334,000 -95% 31 Dec 2018 20-F/A 23 Jan 2020 2018 FY
Q4 2017 $353,000 -$201,000 -36% 31 Dec 2017 20-F/A 23 Jan 2020 2018 FY
Q4 2016 $554,000 -$85,000 -13% 31 Dec 2016 20-F 23 Apr 2018 2017 FY
Q4 2015 $639,000 -$121,000 -16% 31 Dec 2015 20-F 24 Feb 2017 2016 FY
Q4 2014 $760,000 +$701,000 +1188% 31 Dec 2014 20-F 29 Mar 2016 2015 FY
Q4 2013 $59,000 31 Dec 2013 20-F 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.